Skip to content
Open access

Clinical Reference Percentiles for AI-derived Epicardial Adipose Tissue: A Multicenter Study

Aug 2026 · medRxiv · 0 citations
Medicine

TL;DR

Age- and sex-specific EAT percentiles provide a clinically interpretable framework for contextualizing automated EAT measurements and identifying patients at increased cardiovascular risk and identified elevated risk even among patients with normal BMI.

Abstract

Background and Aims: Epicardial adipose tissue (EAT) has emerged as an important cardiovascular biomarker that reflects both inflammatory and cardiometabolic risk. EAT volume and density vary significantly across populations, yet there is a lack of multicenter studies investigating the predictive value of population-specific EAT percentiles. Methods: In this multicenter study, we retrospectively analyzed low-dose computed tomography correction scans from 42,842 patients undergoing myocardial perfusion imaging. A derivation cohort of 15,082 patients was used to establish sex- and age-specific nomograms for EAT density and EAT volume indexed to body surface area. Percentile-based thresholds were tested for outcome prediction in a validation cohort of 27,760 patients. For clinical implementation, we developed an online EAT percentile calculator. Results: Percentile curves demonstrated increased BSA-indexed EAT volume and decreasing EAT density with age. Over a median follow-up of 3.6 years (IQR: 1.83 - 5.14), 4,956 patients experienced a nonfatal myocardial infarction or death. In multivariable Cox models, patients above the 95th sex- and age-specific percentile had significantly worse outcomes for BSA- indexed EAT volume [adjusted hazard ratio 1.30, 95% CI: 1.14 - 1.49, p < 0.001] and EAT density [adjusted hazard ratio 1.7, 95% CI: 1.51 - 1.92, p<0.001] when compared to patients below the 50th percentile (p<0.001). Conclusion: Age- and sex-specific EAT percentiles provide a clinically interpretable framework for contextualizing automated EAT measurements and identifying patients at increased cardiovascular risk. EAT density was a stronger prognostic marker and identified elevated risk even among patients with normal BMI, supporting its potential to provide information beyond conventional anthropometric assessment.

Read PDF

Similar papers

Open access Aug 2026

Epicardial Adipose Tissue and Long-Term Outcomes in CMR-Confirmed MINOCA.

Among patients with CMR-confirmed MINOCA, higher EATVi was associated with an increased long-term risk of MACE, and the potential influence of metabolic factors and residual confounding requires validation in larger external cohorts.

Lei Chen, Wen-Su Chen, De-Xiang Zong et al. · 0 citations
Open access Sep 2026

Epicardial Adipose Tissue Shows No Significant Incremental Value for Discriminating Coronary Artery Disease in Adults Aged 80 Years and Older: A Machine Learning Analysis

Background: Epicardial adipose tissue (EAT) has been associated with coronary artery disease (CAD) in middle-aged and mixed-age populations, but its value in adults aged 80 years and older remains uncertain. This study investigated whether computed tomography (CT)-derived EAT volume provides incremental value for discr...

Jing-Yi Li, Zi-Wei Zhu, Xue-Feng Ni et al. · 0 citations
Sep 2026

Epicardial adipose tissue attenuation as an independent marker of cardiovascular outcomes in de novo heart failure (RECOVER-EAT).

BACKGROUND Epicardial adipose tissue (EAT) is a visceral fat depot implicated in cardiovascular disease. While EAT volume has been associated with risk, it provides limited information regarding adipose tissue composition. Computed tomography (CT)-derived EAT attenuation is a marker of adipose tissue composition, but i...

S. Khanna, N. McLellan, S. Vasanthakumar et al. · 0 citations
Open access Aug 2026

Impact of Dapagliflozin on MRI-Derived Epicardial Adipose Tissue: Secondary Imaging Analysis of a Randomized Trial.

BACKGROUND Epicardial adipose tissue (EAT) is a metabolically active fat depot associated with cardiovascular risk and represents a modifiable imaging biomarker. Studies have shown that sodium-glucose cotransporter-2 (SGLT2) inhibitors reduce EAT thickness in patients with type 2 diabetes mellitus (T2DM). However, it i...

Min Jae Cha, Negar Firoozeh, Anna V. Naumova et al. · 1 citation
Sep 2026

Epicardial Adipose Tissue on Cardiac CT Across Heart Failure Subtypes.

PURPOSE This study evaluated epicardial adipose tissue (EAT) distribution in patients with different heart failure (HF) subtypes using contrast-enhanced cardiac computed tomography (CT), and explores its impact on clinical parameters and prognosis. MATERIALS AND METHODS We retrospectively analyzed 67 heart failure pa...

Ze-Rui Wang, Hui-Jing Chai, Jian Liu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.